BioCentury | Mar 19, 2021
Product Development
Point’s SPAC, Aktis’ A round add to cash flow for radiotherapies: Data Byte
...By KAren Tkach Tuzman, Senior Editor A SPAC for Point Biopharma Inc. and a series A round for Aktis...
...$73 million and Nordic Nanovector ASA (OSE:NANOV) raised $53 million on the public markets. Karen Tkach Tuzman Point Biopharma Inc. Aktis...
...$73 million and Nordic Nanovector ASA (OSE:NANOV) raised $53 million on the public markets. Karen Tkach Tuzman Point Biopharma Inc. Aktis...
